Meridiem Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.7M Buy
+431,042
New +$34.8M 1.51% 22
2026
Q1
Sell
-208,685
Closed -$20M 84
2025
Q4
$20M Sell
208,685
-117,066
-36% -$11.4M 1.21% 35
2025
Q3
$31M Buy
325,751
+147,275
+83% +$13.5M 1.98% 17
2025
Q2
$15.6M Buy
+178,476
New +$15.1M 1.1% 38
2025
Q1
Sell
-157,481
Closed -$12.6M 88
2024
Q4
$12.6M Buy
+157,481
New +$13.6M 1.11% 34

Other funds holding MDT

Meridiem Capital Partners's MDT Position: Q2 2026 in Review

Meridiem Capital Partners opened a new position in Medtronic (MDT) in Q2 2026: 431,042 shares worth $33.7M. The stake represents 1.51% of the portfolio and ranks #22 among its holdings. This is a return to the name: Meridiem Capital Partners previously reported a position in MDT as recently as Q4 2025.

Meridiem Capital Partners first reported a position in MDT in Q4 2024 and has held it in 5 quarters since. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Meridiem Capital Partners held 431,042 shares of Medtronic worth $33.7M as of Q2 2026.
  • Medtronic was a new Meridiem Capital Partners position in Q2 2026.
  • Medtronic made up 1.51% of Meridiem Capital Partners's portfolio in Q2 2026, its #22 holding.
  • Meridiem Capital Partners first reported a position in Medtronic in Q4 2024 and has held it in 5 quarters since.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Meridiem Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.